BioArctic AB Series B (0RV2)
London Exchange · UK · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 298.90 |
|---|---|
| 52-week range | 258.80 – 364.40 |
| Return, 1 month / 3 months | −8.9% / −3.7% |
| Return, 1 year / 3 years | +1.6% / +20.4% |
| Trend | Below its 200-day average |
| RSI (14) | 46 |
| Volatility (1 year) | 42.7% |
| Worst drawdown (1 year) | -20.5% |
| Average daily value traded | 2.00M SEK |
| Dividend yield | 0.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
BioArctic AB Series B (0RV2) trades on the London Exchange in UK. It last closed at SEK 298.90 on 22 October 2026.
Its price-based Market X-Ray is 46 out of 100 (a weak price profile), ranking 2,294 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 1.6% and over the last three months it fell 3.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 45 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -5.6% | ||
| From 52-week high | -16.0% | ||
| Momentum | 47 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -3.7% | ||
| 6-month return | -5.8% | ||
| 12-month return, skipping the last month | 11.5% | ||
| Stability (higher is calmer) | 54 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 42.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -20.5% | ||
| Liquidity | 60 · Fair | Moderate trading activity. | |
| Average daily value traded | 2.00M SEK | ||
| Zero-volume days | 1.7% | ||
| Income | 5 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.7% | ||
| Years with dividends | 1 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.9% |
|---|---|
| 1 month | −8.9% |
| 3 months | −3.7% |
| 6 months | −5.8% |
| 1 year | +1.6% |
| 3 years | +20.4% |
| 5 years | +115.9% |
Signals
| 50-day / 200-day average | 316.75 / 316.49 |
|---|---|
| Golden / death cross (60 days) | Golden, 47 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 14.31 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 May 2026 | SEK 2.0000 |
| 10 May 2019 | SEK 1.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.